<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35458499</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>07</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated Virulence.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">769</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14040769</ELocationID><Abstract><AbstractText>Enteroviruses (EV) are implicated in an extensive range of clinical manifestations, such as pancreatic failure, cardiovascular disease, hepatitis, and meningoencephalitis. We recently reported on the biochemical properties of the highly conserved cysteine residue at position 38 (C38) of enteroviral protein 3A and demonstrated a C38-mediated homodimerization of the Coxsackievirus B3 protein 3A (CVB3-3A) that resulted in its profound stabilization. Here, we show that residue C38 of protein 3A supports the replication of CVB3, a clinically relevant member of the enterovirus genus. The infection of HeLa cells with protein 3A cysteine 38 to alanine mutants (C38A) attenuates virus replication, resulting in comparably lower virus particle formation. Consistently, in a mouse infection model, the enhanced virus propagation of CVB3-3A wt in comparison to the CVB3-3A[C38A] mutant was confirmed and found to promote severe liver tissue damage. In contrast, infection with the CVB3-3A[C38A] mutant mitigated hepatic tissue injury and ameliorated the signs of systemic inflammatory responses, such as hypoglycemia and hypothermia. Based on these data and our previous report on the C38-mediated stabilization of the CVB3-3A protein, we conclude that the highly conserved amino acid C38 in protein 3A enhances the virulence of CVB3.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinkert</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kespohl</LastName><ForeName>Meike</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5897-8747</Identifier><AffiliationInfo><Affiliation>Institute of Biochemistry, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Herz-Kreislauf-Forschung, Partner Side Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gimber</LastName><ForeName>Niclas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9456-3063</Identifier><AffiliationInfo><Affiliation>Institute of Biochemistry, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Advanced Medical Bioimaging Core Facility, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klingel</LastName><ForeName>Karin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0203-2498</Identifier><AffiliationInfo><Affiliation>Cardiopathology, Institute for Pathology and Neuropathology, University of T&#xfc;bingen, 72016 T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmoranzer</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Advanced Medical Bioimaging Core Facility, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laue</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6474-9139</Identifier><AffiliationInfo><Affiliation>Robert Koch Institute, Advanced Light and Electron Microscopy (ZBS 4), 13353 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaida</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Pathology, University Medical Center Mainz, JGU-Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Immunotherapy, University Medical Center Mainz, JGU-Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Unit Immunopathology, Institute of Pathology, University Medical Center, JGU-Mainz and TRON, Translational Oncology at the University Medical Center, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kloetzel</LastName><ForeName>Peter-Michael</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beling</LastName><ForeName>Antje</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1826-5248</Identifier><AffiliationInfo><Affiliation>Institute of Biochemistry, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Herz-Kreislauf-Forschung, Partner Side Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI="D003545">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">animal model</Keyword><Keyword MajorTopicYN="N">coxsackievirusB3</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">virulence regulation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35458499</ArticleId><ArticleId IdType="pmc">PMC9029043</ArticleId><ArticleId IdType="doi">10.3390/v14040769</ArticleId><ArticleId IdType="pii">v14040769</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thibaut H.J., De Palma A.M., Neyts J. Combating enterovirus replication: State-of-the-art on antiviral research. Biochem. Pharmacol. 2012;83:185&#x2013;192. doi: 10.1016/j.bcp.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2011.08.016</ArticleId><ArticleId IdType="pubmed">21889497</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitton J.L., Cornell C.T., Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 2005;3:765&#x2013;776. doi: 10.1038/nrmicro1284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1284</ArticleId><ArticleId IdType="pubmed">16205710</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Haydon D.T., Knowles N.J., McCauley J.W. Molecular evolution of swine vesicular disease virus. Pt 3J. Gen. Virol. 1999;80:639&#x2013;651. doi: 10.1099/0022-1317-80-3-639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-80-3-639</ArticleId><ArticleId IdType="pubmed">10092004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallewaard N.L., Zhang L., Chen J.W., Guttenberg M., Sanchez M.D., Bergelson J.M. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe. 2009;6:91&#x2013;98. doi: 10.1016/j.chom.2009.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.05.018</ArticleId><ArticleId IdType="pmc">PMC2761025</ArticleId><ArticleId IdType="pubmed">19616768</ArticleId></ArticleIdList></Reference><Reference><Citation>Koestner W., Spanier J., Klause T., Tegtmeyer P.K., Becker J., Herder V., Borst K., Todt D., Lienenklaus S., Gerhauser I., et al. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice. PLoS Pathog. 2018;14:e1007235. doi: 10.1371/journal.ppat.1007235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007235</ArticleId><ArticleId IdType="pmc">PMC6107283</ArticleId><ArticleId IdType="pubmed">30075026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kespohl M., Bredow C., Klingel K., Voss M., Paeschke A., Zickler M., Poller W., Kaya Z., Eckstein J., Fechner H., et al. Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming. Sci. Adv. 2020;6:eaay1109. doi: 10.1126/sciadv.aay1109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aay1109</ArticleId><ArticleId IdType="pmc">PMC7065878</ArticleId><ArticleId IdType="pubmed">32195343</ArticleId></ArticleIdList></Reference><Reference><Citation>Althof N., Harkins S., Kemball C.C., Flynn C.T., Alirezaei M., Whitton J.L. In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease. J. Virol. 2014;88:5087&#x2013;5099. doi: 10.1128/JVI.00184-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00184-14</ArticleId><ArticleId IdType="pmc">PMC3993796</ArticleId><ArticleId IdType="pubmed">24574394</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahnefeld A., Klingel K., Schuermann A., Diny N.L., Althof N., Lindner A., Bleienheuft P., Savvatis K., Respondek D., Opitz E., et al. Ubiquitin-Like Protein ISG15 (Interferon-Stimulated Gene of 15 kDa) in Host Defense Against Heart Failure in a Mouse Model of Virus-Induced Cardiomyopathy. Circulation. 2014;130:1589&#x2013;1600. doi: 10.1161/CIRCULATIONAHA.114.009847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.009847</ArticleId><ArticleId IdType="pubmed">25165091</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H.J., Strating J., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368&#x2013;381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball C.C., Harkins S., Whitmire J.K., Flynn C.T., Feuer R., Whitton J.L. Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PLoS Pathog. 2009;5:e1000618. doi: 10.1371/journal.ppat.1000618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000618</ArticleId><ArticleId IdType="pmc">PMC2757675</ArticleId><ArticleId IdType="pubmed">19834548</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornell C.T., Kiosses W.B., Harkins S., Whitton J.L. Coxsackievirus B3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I. J. Virol. 2007;81:6785&#x2013;6797. doi: 10.1128/JVI.00198-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00198-07</ArticleId><ArticleId IdType="pmc">PMC1933326</ArticleId><ArticleId IdType="pubmed">17442717</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita K., Krishnakumar S.S., Franco D., Paul A.V., London E., Wimmer E. Membrane topography of the hydrophobic anchor sequence of poliovirus 3A and 3AB proteins and the functional effect of 3A/3AB membrane association upon RNA replication. Biochemistry. 2007;46:5185&#x2013;5199. doi: 10.1021/bi6024758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi6024758</ArticleId><ArticleId IdType="pmc">PMC2519882</ArticleId><ArticleId IdType="pubmed">17417822</ArticleId></ArticleIdList></Reference><Reference><Citation>Doedens J.R., Giddings T.H., Jr., Kirkegaard K. Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: Genetic and ultrastructural analysis. J. Virol. 1997;71:9054&#x2013;9064. doi: 10.1128/jvi.71.12.9054-9064.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.71.12.9054-9064.1997</ArticleId><ArticleId IdType="pmc">PMC230206</ArticleId><ArticleId IdType="pubmed">9371562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E., Duijsings D., Notebaart R.A., Melchers W.J., van Kuppeveld F.J. A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-golgi transport. J. Virol. 2005;79:5163&#x2013;5173. doi: 10.1128/JVI.79.8.5163-5173.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.8.5163-5173.2005</ArticleId><ArticleId IdType="pmc">PMC1069528</ArticleId><ArticleId IdType="pubmed">15795300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hope D.A., Diamond S.E., Kirkegaard K. Genetic dissection of interaction between poliovirus 3D polymerase and viral protein 3AB. J. Virol. 1997;71:9490&#x2013;9498. doi: 10.1128/jvi.71.12.9490-9498.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.71.12.9490-9498.1997</ArticleId><ArticleId IdType="pmc">PMC230255</ArticleId><ArticleId IdType="pubmed">9371611</ArticleId></ArticleIdList></Reference><Reference><Citation>Horova V., Lyoo H., R&#xf3;&#x17c;ycki B., Chalupska D., Smola M., Humpolickova J., Strating J., van Kuppeveld F.J.M., Boura E., Klima M. Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites. PLoS Pathog. 2019;15:e1007962. doi: 10.1371/journal.ppat.1007962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007962</ArticleId><ArticleId IdType="pmc">PMC6695192</ArticleId><ArticleId IdType="pubmed">31381608</ArticleId></ArticleIdList></Reference><Reference><Citation>Smola M., Horova V., Boura E., Klima M. Structural basis for hijacking of the host ACBD3 protein by bovine and porcine enteroviruses and kobuviruses. Arch. Virol. 2020;165:355&#x2013;366. doi: 10.1007/s00705-019-04490-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-019-04490-9</ArticleId><ArticleId IdType="pubmed">31845156</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E., Duijsings D., Niu T.K., Neumann S., Oorschot V.M., de Lange F., Lanke K.H., Klumperman J., Henke A., Jackson C.L., et al. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev. Cell. 2006;11:191&#x2013;201. doi: 10.1016/j.devcel.2006.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2006.06.005</ArticleId><ArticleId IdType="pubmed">16890159</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L., Derisi J.L. The 3A protein from multiple picornaviruses utilizes the golgi adaptor protein ACBD3 to recruit PI4KIIIbeta. J. Virol. 2012;86:3605&#x2013;3616. doi: 10.1128/JVI.06778-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06778-11</ArticleId><ArticleId IdType="pmc">PMC3302542</ArticleId><ArticleId IdType="pubmed">22258260</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E., Notebaart R.A., Duijsings D., Lanke K., Vergeer B., Melchers W.J., van Kuppeveld F.J. Structure-function analysis of the coxsackievirus protein 3A: Identification of residues important for dimerization, viral rna replication, and transport inhibition. J. Biol. Chem. 2006;281:28232&#x2013;28243. doi: 10.1074/jbc.M601122200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M601122200</ArticleId><ArticleId IdType="pubmed">16867984</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss M., Braun V., Bredow C., Kloetzel P.M., Beling A. Coxsackievirus B3 Exploits the Ubiquitin-Proteasome System to Facilitate Viral Replication. Viruses. 2021;13:1360. doi: 10.3390/v13071360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071360</ArticleId><ArticleId IdType="pmc">PMC8310229</ArticleId><ArticleId IdType="pubmed">34372566</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss M., Kleinau G., Gimber N., Janek K., Bredow C., Thery F., Impens F., Schmoranzer J., Scheerer P., Kloetzel P.M., et al. A cytosolic disulfide bridge-supported dimerization is crucial for stability and cellular distribution of Coxsackievirus B3 protein 3A. FEBS J. :2022. doi: 10.1111/febs.16368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.16368</ArticleId><ArticleId IdType="pubmed">35066984</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetel&#xe4;inen R.L., Bennink R.J., de Bruin K., van Vliet A., van Gulik T.M. Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model. Eur. J. Nucl. Med. Mol. Imaging. 2006;33:1107&#x2013;1114. doi: 10.1007/s00259-006-0125-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-006-0125-3</ArticleId><ArticleId IdType="pubmed">16738848</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhy D.A., Giddings T.H., Jr., Kirkegaard K. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: An autophagy-like origin for virus-induced vesicles. J. Virol. 2000;74:8953&#x2013;8965. doi: 10.1128/JVI.74.19.8953-8965.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.19.8953-8965.2000</ArticleId><ArticleId IdType="pmc">PMC102091</ArticleId><ArticleId IdType="pubmed">10982339</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J., Liu J., Culty M., Papadopoulos V. Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): An emerging signaling molecule. Prog. Lipid Res. 2010;49:218&#x2013;234. doi: 10.1016/j.plipres.2009.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2009.12.003</ArticleId><ArticleId IdType="pmc">PMC2873055</ArticleId><ArticleId IdType="pubmed">20043945</ArticleId></ArticleIdList></Reference><Reference><Citation>Lama J., Sanz M.A., Rodr&#xed;guez P.L. A role for 3AB protein in poliovirus genome replication. J. Biol. Chem. 1995;270:14430&#x2013;14438. doi: 10.1074/jbc.270.24.14430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.24.14430</ArticleId><ArticleId IdType="pubmed">7782305</ArticleId></ArticleIdList></Reference><Reference><Citation>Abernathy E., Mateo R., Majzoub K., van Buuren N., Bird S.W., Carette J.E., Kirkegaard K. Differential and convergent utilization of autophagy components by positive-strand RNA viruses. PLoS Biol. 2019;17:e2006926. doi: 10.1371/journal.pbio.2006926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2006926</ArticleId><ArticleId IdType="pmc">PMC6334974</ArticleId><ArticleId IdType="pubmed">30608919</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y., Shi J., Qu J., Poon T., Xue Y.C., Deng H., Zhang J., Luo H. Enteroviral Infection Inhibits Autophagic Flux via Disruption of the SNARE Complex to Enhance Viral Replication. Cell Rep. 2018;22:3292&#x2013;3303. doi: 10.1016/j.celrep.2018.02.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.02.090</ArticleId><ArticleId IdType="pubmed">29562184</ArticleId></ArticleIdList></Reference><Reference><Citation>Laue M. Electron microscopy of viruses. Methods Cell Biol. 2010;96:1&#x2013;20. doi: 10.1016/S0091-679X(10)96001-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0091-679X(10)96001-9</ArticleId><ArticleId IdType="pubmed">20869516</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>